The recommended baseline panel for menopausal women considering weight loss peptides includes: fasting glucose and HbA1c (metabolic baseline), fasting insulin (insulin resistance assessment), lipid panel including triglycerides (cardiovascular risk), complete metabolic panel (liver and kidney function), IGF-1 (baseline for GH secretagogue monitoring), thyroid panel including TSH and free T4, estradiol and FSH (menopausal status confirmation), and DEXA scan if available (body composition baseline)
Figure 5B)
Genovese, G
TCA, tricarboxylic acid cycle
Gradual Dose Increase for Better Tolerance If you experience nausea or other side effects, you may need to increase your dose more slowly than the standard schedule
We maintain a PA letter librarywith plan-and-condition letter templates for Aetna, Cigna, UnitedHealthcare, Anthem BCBS, Kaiser, Humana, Tricare, FEHB, and Medicare Advantage